Controversies regarding shielding and susceptibility to COVID-19 disease in liver transplant recipients in the United Kingdom

Transpl Infect Dis. 2020 Oct;22(5):e13352. doi: 10.1111/tid.13352. Epub 2020 Jun 17.

Authors

Angus John Hann^{1

2}, Hanns Lembach¹, Siobhan C McKay¹, Moira Perrin¹, John Isaac¹, Ye H Oo^{1

2}, David Mutimer¹, Darius F Mirza¹, Hermien Hartog¹, Thamara Perera¹

Affiliations

¹ The Liver Unit, Elizabeth Hospital Birmingham, Birmingham, UK.
² Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Cross Infection*
Humans
Liver Transplantation*
Middle East Respiratory Syndrome Coronavirus*
Risk Factors
SARS-CoV-2
Transplant Recipients
United Kingdom